Intomics

Intomics, founded by leading scientists in the fields of bioinformatics and systems biology, accelerates and improves drug discovery and development by optimizing the utilization of biomedical data. With extensive experience in a wide range of biomedical data types and a high success rate in disease-related research, the founders believe that the pharmaceutical industry can benefit from their groundbreaking work.Since its establishment, Intomics has been assisting clients in the pharmaceutical industry with various projects involving bioinformatics and systems biology. Intomics' services have expanded into new areas of pharmaceutical R&D, gaining deep knowledge in applying big biomedical data across the entire drug development value chain. Always focused on building close collaborations, Intomics maximizes the synergy between clients' specific disease knowledge and unique capabilities and technical solutions. The mission is to enable the pharmaceutical industry to develop new drug therapies more efficiently by using integrated bioinformatics and systems biology technologies. The vision is to become the leading and most advanced provider of integrated bioinformatics and systems biology technologies in the pharmaceutical industry.